William Penn Bancorp (WMPN) 21.5000 $WMPN William Penn

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
William Penn Bancorp (WMPN) 21.5000 $WMPN

William Penn Bancorp, Inc. Announces Third Quarter Earnings
Marketwired - Tue Apr 26, 9:30AM CDT
William Penn Bancorp, Inc. (the "Company" (OTC PINK: WMPN) announced net income of $708,000 ($0.21 per basic and diluted share) for the three months ended March 31, 2016 as compared to $725,000 ($0.21 per basic and diluted share) for the same period last year. Net interest income after provision for loan losses remained virtually the same for the three months ended March 31, 2016 and March 31, 2015. Income before income taxes decreased to $1,070,000 for the three months ended March 31, 2016, from $1,095,000 for the three months ended March 31, 2015. This decrease was primarily due to decrease in noninterest income to $114,000 for three months ended March 31, 2016 from $133,000 for the same period ended March 31, 2015. The Company had total assets of $320.2 million at March 31, 2016 as compared to $319.3 million at June 30, 2015.

William Penn Bancorp, Inc. and William Penn, MHC Complete 2015 Stock Repurchase Plans
ACCESSWIRE - Tue Apr 12, 10:00AM CDT
LEVITTOWN, PA / ACCESSWIRE / April 12, 2016 / William Penn Bancorp, Inc. (OTC Pink: WMPN), the holding company for William Penn Bank (the "Company", announced today that it had completed the repurchase of all stock available for repurchase under the plan announced in December 2015. As a result, the Company has completed repurchases under such plan. The Company now has 877,641 shares of common stock outstanding, excluding shares held by William Penn MHC.

William Penn Bancorp, Inc. and William Penn, MHC Announce Stock Repurchase Programs
ACCESSWIRE - Thu Dec 17, 2:00PM CST
LEVITTOWN, PA / ACCESSWIRE / December 17, 2015 / William Penn Bancorp, Inc. (OTC Pink: WMPN) (the "Company", the holding company for William Penn Bank, announced today that the Board of Directors has authorized the Company to repurchase up to approximately 38,332 shares, or 4%, of the Company's outstanding common stock, excluding shares held by William Penn, MHC ("MHC". In addition, the MHC, the majority shareholder of the Company, announced today that its Board of Directors has also approved the purchase of 38,332 shares, or 4%, of the Company's common stock, excluding shares held by the MHC. The repurchases will be made from time to time in open market or privately negotiated transactions at the discretion of management during the next twelve months, or such shorter or longer time as the Company may decide, subject to the availability of stock. The timing of the repurchases will depend on market conditions and other requirements. Terry L. Sager, President of the Company, stated that "we believe, at current levels, the repurchase of our public shares of common stock represents an appropriate use of our capital and could potentially enhance shareholder value in the Company by increasing return on equity and net income per share."

William Penn Bancorp, Inc. Announces First Quarter Earnings
ACCESSWIRE - Mon Nov 23, 10:30AM CST
LEVITTOWN, PA / ACCESSWIRE / November 23, 2015 / William Penn Bancorp, Inc. (PINKSHEETS: WMPN) announced net income of $641,000 ($0.18 per basic and diluted share) for the three months ended September 30, 2015 as compared to $624,000 ($0.17 per basic and diluted share) for the same period last year. Net interest income after provision for the three months ended September 30, 2015 was $2,129,000 as compared to net interest income after provision of $2,110,000 for the same period ending September 30, 2014. This increase was mainly attributable to a decrease in interest expense to $914,000 at September 30, 2015 from $961,000 at September 30, 2014. William Penn Bancorp, Inc. had assets of $310.8 million at September 30, 2015 as compared to $319.3 million at June 30, 2015.

William Penn Bancorp, Inc. Declares Annual Cash Dividend
ACCESSWIRE - Thu Jul 16, 9:30AM CDT
LEVITTOWN, PA / ACCESSWIRE / July 16, 2015 / William Penn Bancorp, Inc. (PINKSHEETS: WMPN), the mid-tier holding company for William Penn Bank, Levittown, Pennsylvania, today announced the declaration of a $0.27 per share annual cash dividend, payable on August 12, 2015 to stockholders of record as of the close of business on August 3, 2015. The directors voted to pay this dividend after reviewing the Company's results of operations and financial condition at and for the fiscal year ended June 30, 2015. "This is our fourth consecutive annual dividend and represents an increase of $0.01 per share from last year's regular dividend. We are able to pay this dividend as a result of the continued profitability of the Company. Our Board of Directors is strongly committed to enhancing shareholder value in our Company," remarked Terry L. Sager, President and Chief Executive Officer, of William Penn Bancorp, Inc.

William Penn Bancorp, Inc. Completes 2014 Stock Repurchase Plan
PR Newswire - Thu Jun 04, 10:00AM CDT
William Penn Bancorp, Inc. (OTC Pink: WMPN), the holding company for William Penn Bank, announced today that it had completed the repurchases of all stock available for repurchase under the repurchase plan announced in December 2014. As a result, the Company has terminated the 2014 stock repurchase plan. The Company now has 958,305 shares of common stock outstanding, excluding shares held by William Penn MHC.

William Penn Bancorp, Inc. Announces 10% Stock Repurchase Plan
PR Newswire - Wed Dec 03, 2:35PM CST
William Penn Bancorp, Inc. (OTC Bulletin Board: WMPN), the holding company for William Penn Bank, announced today that the Board of Directors has authorized the Company to repurchase up to approximately 109,230 shares or 10% of the Company's outstanding common stock, excluding shares held by William Penn MHC. The repurchases will be made from time to time in open market or privately negotiated transactions at the discretion of management during the next twelve months, or such shorter or longer time as the Company may decide, subject to the availability of stock. The timing of the repurchases will depend on market conditions and other requirements. Terry L. Sager, President of the Company, stated that "we believe, at current levels, the repurchase of our public shares of common stock represents an appropriate use of our capital and could potentially enhance shareholder value in the Company by increasing return on equity and net income per share."

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading